Self-efficacy for coping with cancer among cancer survivors with preexisting mental health conditions versus a control group

IF 1.5 4区医学 Q2 PSYCHIATRY

European Journal of Psychiatry Pub Date : 2025-07-25 DOI:10.1016/j.ejpsy.2025.100318

Miri Cohen , Marc Gelkopf

{"title":"Self-efficacy for coping with cancer among cancer survivors with preexisting mental health conditions versus a control group","authors":"Miri Cohen , Marc Gelkopf","doi":"10.1016/j.ejpsy.2025.100318","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and objectives</h3><div>Self-efficacy for coping with cancer is a significant factor for cancer survivors’ quality of life, but it has not been examined among individuals with preexisting severe mental health conditions (SMHC). This study compared perceptions of self-efficacy for coping with cancer among cancer survivors with and without precancer SMHC; quality of communication with the oncology team and depressive symptoms as antecedents of self-efficacy; and the mediating role of self-regulation (cognitive reappraisal and expressive suppression) between antecedents and perceived self-efficacy for coping with cancer.</div></div><div><h3>Methods</h3><div>Participants were 170 adult cancer survivors with preexisting SMHC and 80 with no SMHC, aged 20–71, and 1–5 years since diagnosis. They filled out questionnaires in a face-to-face meeting. Multigroup path analysis was conducted using structural equation modeling.</div></div><div><h3>Results</h3><div>Individuals with SMHC reported lower self-efficacy for coping with cancer and higher levels of depressive symptoms. In the SMHC group, cognitive reappraisal mediated the association between perceived communication quality and self-efficacy, and expressive suppression mediated the relationship between depressive symptoms and self-efficacy.</div></div><div><h3>Conclusions</h3><div>The results highlight the deficiency in self-efficacy for coping with cancer in individuals with SMHC, a prominent factor for treatment adherence and quality of life among cancer survivors. Findings suggest self-efficacy may be strengthened via more emphatic and attentive communication with the oncology team and fostering effective emotion regulation strategies.</div></div>","PeriodicalId":12045,"journal":{"name":"European Journal of Psychiatry","volume":"39 4","pages":"Article 100318"},"PeriodicalIF":1.5000,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0213616325000291","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 0

Abstract

Background and objectives

Self-efficacy for coping with cancer is a significant factor for cancer survivors’ quality of life, but it has not been examined among individuals with preexisting severe mental health conditions (SMHC). This study compared perceptions of self-efficacy for coping with cancer among cancer survivors with and without precancer SMHC; quality of communication with the oncology team and depressive symptoms as antecedents of self-efficacy; and the mediating role of self-regulation (cognitive reappraisal and expressive suppression) between antecedents and perceived self-efficacy for coping with cancer.

Methods

Participants were 170 adult cancer survivors with preexisting SMHC and 80 with no SMHC, aged 20–71, and 1–5 years since diagnosis. They filled out questionnaires in a face-to-face meeting. Multigroup path analysis was conducted using structural equation modeling.

Results

Individuals with SMHC reported lower self-efficacy for coping with cancer and higher levels of depressive symptoms. In the SMHC group, cognitive reappraisal mediated the association between perceived communication quality and self-efficacy, and expressive suppression mediated the relationship between depressive symptoms and self-efficacy.

Conclusions

The results highlight the deficiency in self-efficacy for coping with cancer in individuals with SMHC, a prominent factor for treatment adherence and quality of life among cancer survivors. Findings suggest self-efficacy may be strengthened via more emphatic and attentive communication with the oncology team and fostering effective emotion regulation strategies.

查看原文本刊更多论文

先前存在心理健康问题的癌症幸存者与对照组之间应对癌症的自我效能感

背景与目的应对癌症的自我效能感是影响癌症幸存者生活质量的一个重要因素，但尚未在患有严重精神健康状况（SMHC）的个体中进行研究。本研究比较了有和没有癌前SMHC的癌症幸存者应对癌症的自我效能感；与肿瘤团队的沟通质量和抑郁症状作为自我效能感的先决条件；自我调节（认知重评和表达抑制）在应对癌症的前因由和感知自我效能之间的中介作用。方法研究对象为年龄在20-71岁、诊断后1-5年、既往存在SMHC的成年癌症幸存者170例和未存在SMHC的80例。他们在面对面的会议中填写了问卷。采用结构方程模型进行多组路径分析。结果SMHC患者在应对癌症方面的自我效能较低，而抑郁症状水平较高。在SMHC组中，认知重评介导了感知沟通质量与自我效能感的关系，表达抑制介导了抑郁症状与自我效能感的关系。结论SMHC患者应对癌症的自我效能感不足，这是影响癌症幸存者治疗依从性和生活质量的重要因素。研究结果表明，自我效能感可以通过与肿瘤团队进行更加强调和细心的沟通以及培养有效的情绪调节策略来增强。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Journal of Psychiatry PSYCHIATRY-

CiteScore

2.90

自引率

0.00%

发文量

审稿时长

43 days

期刊介绍： The European journal of psychiatry is a quarterly publication founded in 1986 and directed by Professor Seva until his death in 2004. It was originally intended to report “the scientific activity of European psychiatrists” and “to bring about a greater degree of communication” among them. However, “since scientific knowledge has no geographical or cultural boundaries, is open to contributions from all over the world”. These principles are maintained in the new stage of the journal, now expanded with the help of an American editor.